Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.
Department of Dermatology and Cutaneous Surgery, University of Miami Leonard M. Miller School of Medicine, Miami, FL, USA.
Arch Dermatol Res. 2024 Apr 16;316(5):119. doi: 10.1007/s00403-024-02851-2.
This paper explores the role of teledermatology (TD) in Mohs micrographic surgery (MMS) at various stages of patient care. The study aims to assess the benefits, limitations, and patient experiences surrounding TD integration into MMS practices. We conducted a PubMed search using keywords related to TD and MMS, categorizing selected articles into pre-operative, intra-operative, and post-operative stages of MMS. TD reduced waiting times (26.10 days for TD compared to 60.57 days for face-to-face [FTF]) and consultation failure rates (6% for TD vs. 17% for FTF) for MMS preoperative consultations. It also shortened time to treatment by two weeks and led to notable travel savings (162.7 min, 144.5 miles, and $60.00 per person). Telepathology facilitated communication and decision-making during MMS, improving accuracy and efficiency, especially in challenging cases requiring collaboration where physical presence of another surgeon or pathologist is not feasible. Telepathology definitively diagnosed benign lesions and malignant tumors in 81.8% of cases (18/22). Additionally, there was a 95% agreement between conventional light microscopy diagnosis and telepathology in tumors (19/20), and 100% agreement for all 20 Mohs frozen section consultations. For post-operative follow-up, telephone follow-up (TFU) and text messaging proved effective, cost-efficient alternatives with high patient satisfaction (94% in New Zealand and 96% in the U.K.) and early complication identification. This study underscores TD's multifaceted benefits in MMS: enhanced patient experience preoperatively, improved communication during surgery, and cost-effective postoperative follow-up. Limitations include the financial expense and technical issues that can arise with TD (connectivity problems, delays in video/audio transmission, etc.). Further studies are needed to explore emerging TD modalities in post-operative patient management. The integration of TD into MMS signifies a progressive step in dermatological care, offering convenient, cost-effective, and better solutions with the potential to enhance patient experiences and outcomes.
本文探讨了远程皮肤病学(TD)在各种患者护理阶段的 Mohs 显微外科手术(MMS)中的作用。本研究旨在评估将 TD 整合到 MMS 实践中的益处、限制和患者体验。我们使用与 TD 和 MMS 相关的关键词在 PubMed 上进行了搜索,将选定的文章分为 MMS 的术前、术中、和术后阶段。TD 减少了 MMS 术前咨询的等待时间(TD 为 26.10 天,面对面 [FTF] 为 60.57 天)和咨询失败率(TD 为 6%,FTF 为 17%)。它还将治疗时间缩短了两周,并带来了显著的旅行节省(每人 162.7 分钟、144.5 英里和 60.00 美元)。远程病理学促进了 MMS 期间的沟通和决策,提高了准确性和效率,特别是在需要协作的具有挑战性的病例中,在这些病例中,由于另一位外科医生或病理学家的实际存在不可行。远程病理学在 81.8%的情况下明确诊断良性病变和恶性肿瘤(18/22)。此外,在肿瘤的常规光镜诊断和远程病理学之间有 95%的一致性(19/20),在所有 20 例 Mohs 冷冻切片咨询中均有 100%的一致性。对于术后随访,电话随访(TFU)和短信证明是有效的、具有成本效益的替代方案,患者满意度高(新西兰为 94%,英国为 96%),并能及早识别并发症。本研究强调了 TD 在 MMS 中的多方面益处:术前增强患者体验、手术期间改善沟通以及术后具有成本效益的随访。局限性包括 TD 可能出现的财务费用和技术问题(连接问题、视频/音频传输延迟等)。需要进一步研究来探索术后患者管理中新兴的 TD 模式。将 TD 整合到 MMS 中标志着皮肤科护理的一个进步步骤,提供了便捷、具有成本效益的更好解决方案,有可能增强患者体验和结果。